Axiora Medical
Axiora Medical
Select premium trauma reconstruction and orthopedic soft-tissue repair components engineered for demanding clinical applications in Israel's top healthcare institutes.
Israel is renowned globally as a high-technology hub for medical innovation. The local Israeli ecosystem, centered around technological hubs in Tel Aviv, Haifa, and Rehovot, drives groundbreaking R&D in surgical navigation, robotics, and biocompatible materials. However, scaling manufacturing from prototype to mass production presents a significant economic and supply chain hurdle for local medical device firms and distributors.
This is where strategic global sourcing with Class III cleanroom factories in China becomes crucial. Distributors and hospitals in Israel demand surgical implants that match their rigorous clinical standards (including ISO 13485 and AMAR registration guidelines) while providing sustainable unit economics.
By partnering with a major orthopedic manufacturer like Axiora Medical, Israeli companies can leverage the ultimate manufacturing arbitrage: high-end quality controls matching Western standards combined with the high scalability and speed of China's medical supply chain.
"For Israeli medical distributors, having a production pipeline that can deliver CE-compliant, sterile-packaged trauma sutures and knotless anchors on demand is a critical operational advantage in winning institutional tenders."
A deep dive into our structural specifications, testing benchmarks, and global OEM/ODM capabilities.
| System Metric | Axiora Medical Technical Standard & Operations |
|---|---|
| Company Name & Brand | Axiora Medical Technology (China) Co., Ltd. (Brand: Axiora) |
| Manufacturing Experience | 15 Years Industry R&D, 8 Years Global Export Experience (Est. 2017) |
| Factory Infrastructure | 18,600 m² Facility utilizing Class 10,000 (ISO Class 7) aseptic packaging cleanrooms |
| Annual Export & Volume | USD 26 Million across Europe, the Middle East (Israel, UAE), and North America |
| Raw Material Certifications | ASTM F136 Implant-Grade Titanium Alloy, ASTM F2026 Biocompatible PEEK, Ultra-High-Molecular-Weight Polyethylene (UHMWPE) |
| Quality Control Protocol | 100% Finished Product Inspection, OQC & Incoming Inspection by 48 Dedicated Specialists |
| Inspection Assets | Coordinate Measuring Machines (CMM), Tensile Strength Testers, Hardness Testing, Surface Roughness Inspection, Aging & Fatigue Testers, Salt Spray Chambers |
| R&D Infrastructure | 86 R&D Engineers releasing over 120 new sports medicine & trauma components annually |
Our 18,600 m² facility utilizes state-of-the-art CNC tooling, multi-stage ultrasonic cleaning, and Class III medical aseptic packaging.
Navigating Israel's Ministry of Health (MOH) medical device regulatory framework (AMAR approval) requires immaculate documentation and validation. Axiora Medical simplifies this barrier for Israeli distributors by providing direct and complete regulatory dossier packages.
Whether registering high-strength biocompatible sutures or complex arthroscopic instruments, our dedicated quality assurance team provides technical dossiers built to FDA 510(k), CE MDR, and ISO 13485:2016 standards.
Certified Class III systems ensure clean medical audits and simple approval processes in European and Israeli jurisdictions.
From melting point analysis of PEEK raw blocks to tool-wear paths during CNC cutting, our traceability is total.
Why premier orthopedic distributors in Israel choose Axiora Medical Technology as their long-term production backbone.
We source medical implant materials from internationally verified suppliers, offering raw material chemistry validation sheets for every batch of PEEK or titanium alloys.
Our 86 R&D engineers use high-fidelity CAD/CAM software to turn design ideas into dynamic physical prototypes in under 15 working days.
A capacity of 1,120 partner nodes throughout China's dynamic medical industrial parks secures consistent shipping schedules even during supply crunches.
Explore our CE Certified, biocompatible anchors and surgical revision sets designed for ACL/PCL reconstruction, rotator cuff repair, and joint stabilization.
Understand the shifts in regulatory standards, materials science, and inventory control shaping modern orthopedic device sourcing.
Surgeons are shifting away from traditional titanium towards osteoconductive biocomposites. These materials break down over time, supporting natural bone growth and removing the need for follow-up implant removal operations.
Knotless anchor configurations have become the clinical standard. They reduce procedural time in the operating room while minimizing knot-slippage and impingement risks for patients.
Distributors increasingly select implants pre-packaged in ISO-certified double aseptic barriers. This approach minimizes risk at the hospital point-of-use and streamlines regional import processes.
Answers to critical questions regarding compliance, registration, and production timelines for Israeli medical device importers.
Request detailed product brochures, bulk quotation structures, or customized OEM validation timelines tailored for the Israeli orthopedic sector.
Send Inquiry Now
